Skip to Content

Perkins Discovery PDFDX

Medalist Rating as of | See Perkins Investment Hub
  • NAV / 1-Day Return 39.02  /  −1.56 %
  • Total Assets 6.7 Mil
  • Adj. Expense Ratio
    2.500%
  • Expense Ratio 2.500%
  • Distribution Fee Level High
  • Share Class Type No Load
  • Category Health
  • Investment Style Small Growth
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield
  • Turnover 2%

USD | NAV as of Apr 18, 2024 | 1-Day Return as of Apr 18, 2024, 10:21 PM GMT+0

Morningstar’s Analysis PDFDX

Will PDFDX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in Perkins Discovery's Process and People Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings PDFDX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 62.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

ePlus Inc

9.42 718,560
Technology

Natera Inc

9.04 689,040
Healthcare

Veracyte Inc

7.58 577,710
Healthcare

Vericel Corp

7.00 534,150
Healthcare

Perion Network Ltd

6.27 478,485
Communication Services

ANI Pharmaceuticals Inc

5.13 391,494
Healthcare

Option Care Health Inc

4.86 370,590
Healthcare

NeoGenomics Inc

4.67 355,960
Healthcare

Cantaloupe Inc

4.18 318,630
Technology

Asure Software Inc

4.12 314,160
Technology